Comparison of culture and isolation methods for Clostridioides difficile and other anaerobes from stool samples in a routine microbiological laboratory practice

Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):212-216

​ Shvydkaya M.G., Zatevalov A.M., Mitrokhin S.D., Dzhandarova D.T.
10.36488/cmac.2021.2.212-216
culture liquid medium stool samples Clostridium difficile anaerobes
Section
Personal Experience
Type
Original Article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):212-216

Objective.

To improve stool sample culture and isolation of anaerobic flora, including Clostridioides difficile in the routine microbiological laboratory practice at the children’s oncology hospital.

Materials and Methods.

A total of 517 stool samples collected from patients in children’s oncology hospital from 2013 to 2015 were studied. All samples were analyzed by ELISA for C. difficile toxins and by culture according to dedicated 5 schemes for isolation of anaerobic bacteria, including C. difficile. Statistical significance of differences in isolation rates between the studied groups (culture schemes) was assessed by Pearson test.

Results.

Culture in liver broth and covering with technical agar followed by culture on anaerobic agar yielded 100% isolation rate of toxigenic C. difficile strains. This culture scheme is also suitable for isolating concomitant anaerobic flora: non-toxigenic C. difficile strains, Clostridium perfringens, other Clostridia spp. and Bacteroides spp.

Conclusions.

Use of the liquid accumulation medium and covering with technical agar make it possible to isolate anaerobic flora from stool samples and increase an isolation rate of toxigenic C. difficile strains to 100% of ELISA-positive samples.

Maria G. Shvydkaya

G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Zatevalov A.M.

G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Mitrokhin S.D.

City Clinical Hospital

Dzhandarova D.T.

Diagnostic Clinical Center

  • 1. Jain T., Croswell C., Urday-Cornejo V., Awali R., Cutright J., Salimnia H., et al. Clostridium difficile colonization in hematopoietic stem cell transplant recipients: a prospective study of the epidemiology and outcomes involving toxigenic and nontoxigenic strains. Biol Blood Marrow Transplant. 2016;22(1):157-163. DOI: 10.1016/j.bbmt.2015.07.020
  • 2. Al-Rawahi G.N., Al-Najjar A., McDonald R., Deyell R.J., Golding G.R., Brant R., et al. Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission. Pediatr Blood Cancer. 2019;66(5):e27604. DOI: 10.1002/pbc.27604
  • 3. Erb S., Frei R., Strandén A.M., Dangel M., SchudinSutter S.T., Widmer A.F. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients. Clin Microbiol Infect. 2015;21(11):998.e9-998.e15. DOI: 10.1016/j.cmi.2015.07.016
  • 4. Stahlmann J., Schönberg M., Herrmann M., von Müller L. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples. Research Note Epidemiology. 2014;20(9):O590-O592. DOI: 10.1111/14690691.12558
  • 5. Origüen J., Corbella L., Orellana M.Á., Villa J., Delgado R., August A. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test. Clin Microbiol Infect. 2018;24(4):414421 DOI: 10.1016/j.cmi.2017.07.033
  • 6. Clostridium difficile-associated diarrhea. National Association of Specialists in the Control of Infections Associated with the Provision of Medical Care (NP NASCI). Federal clinical guidelines, 2017. Russian.
  • 7. Shelygin Yu.A., Aleshkin V.A., Sukhina M.A., Mironov A.Yu., et al. Clinical recommendations of the National Association of Specialists in Control of Infections Associated with the Provision of Medical Assistance, and the All-Russian Public Non-Profit Organization Association of Coloproctologists of Russia for Diagnostics, treatment and prevention of Clostridium difficile-associated diarrhea (CDI). Koloproktologiya. 2018;3(65):7-23. Russian. DOI: 10.33878/2073-7556-2018-03-7-23
  • 8. Crobach M.J., Planche T., Eckert C., Barbut F., Terveer E.M., Dekkers O.M. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22:S63-S81. DOI: 10.1016/j.cmi.2016.03.010
  • 9. Camorlinga M., Sanchez-Rojas M., Torres J., RomoCastillo M. Phenotypic Characterization of non-toxigenic Clostridioides difficile strains isolated from patients in Mexico. Front Microbiol. 2019;10(84):1-10. DOI: 10.3389/fmicb.2019.00084
  • 10. Chia J.-H., Wu T.-S., Wu T.-L.,Chen C.-L., Chuang C.-H., Su L.-H., et al. Clostridium innocuum is a vancomycinresistant pathogen that may cause antibiotic-associated diarrhoea. Clin Microbiol Infect. 2018;24(11):11951199. DOI: 10.1016/j.cmi.2018.02.015
  • 11. Kiu R., Hall L.J. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018;7:141. DOI: 10.1038/s41426-018-0144-8
  • 12. Yu L.C. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomedical Science. 2018;25(1):79. DOI: 10.1186/s12929-0180483-8
  • 13. Borisov O.O., Efremov E.M. Bacteremia due to Clostridium difficile: literature review. WORLD SCIENCE: PROBLEMS AND INNOVATIONS. Articles of the XXXI International Scientific and Practical Conference. Science and Education. 2019. Russian.
  • 14. Yamamoto Y., Itoh N., Sugiyama T., Kurai H. Clinical features of Clostridium bacteremia in cancer patients: A case series review. J Infect Chemother. 2020;26(1):92-94. DOI: 10.1016/j.jiac.2019.07.019
  • 15. Millard M.A., McManus K. A., Wispelwey B. Severe sepsis due to Clostridium perfringens bacteremia of urinary origin: a case report and systematic review. Case Rep Infect Dis. 2016;2016:2981729. DOI: 10.1155/2016/2981729
  • 16. Madsen R.I., Justesen U.S. Bacteremia with Bacteroides pyogenes after a cat bite. J Clin Microbiol. 2011;49(8): 3092-3093. DOI: 10.1128/JCM.00250-11
  • 17. Hsu G., Chen C., Lai M., Luh S. Chest wall abscess due to Prevotella bivia. J Zhejiang Univ Sci B. 2009;10(3):233236. DOI: 10.1631/jzus.B0820289
  • 18. Di Marco Berardino A., Inchingolo R., Smargiassi A., Re A., Torelli R., Fiori B., et al. Empyema caused by Prevotella bivia complicating an unusual case of spontaneous chylothorax. J Clin Microbiol. 2014;52(4):1284-1286. DOI: 10.1128/JCM.03282-13
  • 19. Mehmood M., Jaffar N. A., Nazim M., Khasawneh F.A. Bacteremic skin and soft tissue infection caused by Prevotella loescheii. BMC Infect Dis. 2014;14:162. DOI: 10.1186/1471-2334-14-162
  • 20. Mo S., Wei L., Chen H., Li R., Li S., Luo G. A chinese case of Prevotella intermedia and Streptococcus constellatus intracranial mixed infection. Metab Brain Dis. 2018;33(1):161-166. DOI: 10.1007/s11011-0170142-x
  • 21. Litusov N.V. Genus Bacteroides. Illustrated tutorial. FGBOU VO USMU, Yekaterinburg, 20172017. 17 p. Russian.
  • 22. Mirzaei E.Z., Rajabnia M., Sadeghi F., FerdosiShahandashti E., Sadeghi-Haddad-Zavareh M., Khafri S., et al. Diagnosis of Clostridium difficile infection by toxigenic culture and PCR assay. Iran J Microbiol 2018;10(5):287293.
  • 23. Shannon S., Gustafson D., Segner R., Ali A., Schieffer B., Boelman K., et al. Comparison of recovery rates of Clostridium difficile from stool using chromogenic agar versus a classic culture method. Available at: www.chromagar.com/fichiers/1470066757Comparison_of_Recovery_Rates_of_Clostridium_difficile_from.pdf. Accessed October 5, 2020.
  • 24. Bauer M.P., Farid A., Bakker M., Hoek R.A.S., Kuijper E.J., van Dissel J.T. Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile. Clin Microbiol Infect. 2014;20(7):O446-O449. DOI: 10.1111/1469-0691.12439
  • 25. Gerding D. N., Meyer T., Lee C., Cohen S.H., Murfy U.K., Poirier A., et al. Administration of spores of nontoxigenic Clostridium difficile strain m3 for prevention of recurrent C. difficile infection. JAMA. 2015;313(17):1719-1727. DOI: 10.1001/jama.2015.3725
  • 26. Kotsanas D. Novel use of tryptose sulfite cycloserine egg yolk agar for isolation of Clostridium perfringens during an outbreak of necrotizing enterocolitis in a neonatal unit. J. Clin. Microbiol. 2010;48:4263-4265. DOI: 10.1128/JCM.01724-10
  • 27. GOST R 53400-2009 (ISO 7937:2000). Microbiology of food and animal feed. Colony counting method for Clostridium perfringens. Russian.
  • 28. Zamani S., Shariati S.H., Zali M.R., Aghdaei H.A., Asiabar A.S., Bokaie S., et al. Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis. Gut Pathog. 2017;9:53. DOI: 10.1186/s13099-017-0202-0
  • 29. Ho P., Ho L., Yau C., Tong M., Chow K. A novel selective medium for isolation of Bacteroides fragilis from clinical specimens. J Clin Microbiol. 2017;55(2):384-390. DOI: 10.1128/JCM.01988-16
  • 30. Ayyagari A., Khanna T., Devi S. Enzyme linked immunosorbent assay & indirect fluorescence assay for rapid diagnosis of Bacteroides fragilis infections. Indian J Med Res. 1992;95:34-40. DOI: 10.1016/s01406736(79)90768-2
  • 31. Lalitha M.K., Mathai E., Elias L., Anandi V., Kalpana C.R. Detection of Bacteroides infection by counter immunoelectrophoresis test. Indian J Med Res. 1991;93:171-173. DOI: 10.1136/jcp.31.11.1078
Views
0 Abstract
0 PDF
0 Crossref citations
Shared